Breaking News: Link 126

Breaking News Links, as part of the research project GESPAM (Geopolitica, Salute Pubblica e Accesso alle Medicine/Geopolitics, Public Health and Access to Medicines), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings


Breaking News 126

Gilead denied patent for hepatitis C drug sofosbuvir in India  

Key Hepatitis C Patent Rejected In India For Lack Of Novelty, Inventive Step  

High priced hepatitis C treatments spark massive public outcry and political debate in Spain  

ISDS decision delayed to end of TTIP talks 

Development aid popular among EU citizens, despite widespread ignorance 

Negotiating financing for development commitments: Lessons from OGP 

Trends in humanitarian policy and practice: What to watch in 2015 


New Ebola cases slump in all three worst-hit countries: WHO  

Where Do We Stand in The Fight Against Ebola? A Conversation with CDC Director Tom Frieden   

Two leading Ebola vaccines show ‘acceptable safety’ – UN health agency   

‘Extreme measures’ needed to see Ebola shot development through   

1st Ebola Clinic For Pregnant Women Opens In Sierra Leone   

UN study finds increase in women managers, urges greater efforts for workforce equality 

Why gay rights is a development issue in Africa, and aid agencies should speak up   

Bangladesh’s politicians should keep their hands off Grameen Bank   

Argentina Celebrates New Year Free of Trans Fats

CARICOM, Trans-Pacific Partnership, And IP Law & Policy: What Next?   

TRIPS, Patents and Innovation: A Necessary Reappraisal?   

End in sight for World Bank’s controversial reforms   

Bad News, and Good, on Antibiotic Resistance  

Guinea worm on the brink of eradication, says Carter Center 

Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites 

WHO grants approval for safe, effective meningitis A vaccine for infants 

Better prevention could cut leprosy complication’s high cost for Indian families – study